275PEfficacy and tolerability of olaparib in Asian patients with recurrent ovarian, primary peritoneal or fallopian tube carcinoma: The National University Cancer Institute, Singapore experience. (25th November 2018) - Heong, V Y M; Lim, Y W; Lee, S C; Ow, S; Lim, S E; Ong, P Y; Low, J; Ng, J; Ilancheran, A; Tong, P; Lim, D; Tan, D